Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate‐to‐severe facial acne vulgaris: A phase 3, multi‐centre, randomized, double‐blind, vehicle‐controlled studyYan Le, Leihong Xiang, Xian Jiang et al.|Journal of the European Academy of Dermatology and Venereology|2024Cited by 5
Efficacy and safety of pumecitinib 3% gel in treating mild-to-moderate atopic dermatitis: a multicentre randomized double-blind parallel placebo-controlled phase IIb clinical trialZhang Li, Mingyue Wang, Litao Zhang et al.|British Journal of Dermatology|2025Cited by 0